Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

17. Janvier 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2940


	Articles 1 - 20 / 58795

	Protein palmitoylation and immune regulation in pancreatic ductal adenocarcinoma: Integrating insights from cross-cancer studies. Biochim Biophys Acta Rev Cancer Cui X, Li C, Zhong X, Sun A, Lan Y, Wang Z. PMID: 41544825 [PubMed - as supplied by publisher]
	Gender Differences in Prognosis of Pancreatic Neuroendocrine Tumors: A Retrospective Cohort Study Based on the SEER Database. Cancer Control Li Y, Zhou S, Qiao Q, Ji K, Li Q, Qiao Z, Zhang P. PMID: 41544666 [PubMed - indexed for MEDLINE]
	ZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review). Int J Mol Med Chen XM, Liang YB, Zuo JX, Yang ZS, Zhang LY, Zhang XY, Wan P, Ke Y. PMID: 41543187 [PubMed - indexed for MEDLINE]
	Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review) . Int J Oncol Rauschenberg S, Orgler-Gasche E, Karakas Zeybek D, Regel I, Löhr JM, Öhlund D, Günther M, Aguilera Munoz L. PMID: 41543183 [PubMed - indexed for MEDLINE]
	Inferring Clinically Relevant Molecular Subtypes of Pancreatic Cancer from Routine Histopathology Using Deep Learning. medRxiv Akbar AR, Levya A, Esnakula A, Hasanov E, Noonan A, Manne U, Sahai V, Meng L, Tsai S, Parwani A, Chen W, Manne A, Khan Niazi MK. PMID: 41542662 [PubMed]
	Circulating tumour DNA (ctDNA) as a predictor of progression-free and overall survival in non-resectable pancreatic cancer: a systematic review and meta-analysis. J Liq Biopsy Steiniche MM, Callesen LB, Vlk EH, Ventzel L, Timm S, Andersen RF, Lindgaard SC, Hansen TF, Ladekarl M, Spindler KG. PMID: 41541743 [PubMed]
	A scoping review of breakthrough cancer pain: Multidimensional patient needs and influencing factors. Asia Pac J Oncol Nurs Li Q, Sheng Y, Liu X, Li J, Zhu L, Yang Y, Hu L. PMID: 41541009 [PubMed]
	Scaffold optimization trends in matrix metalloproteinase inhibitors for selective pancreatic cancer Therapy-A review. Eur J Med Chem Kolli K, Kumar D. PMID: 41539274 [PubMed - as supplied by publisher]
	Impact of pancreatic transection level on survival outcomes and glycemic control following distal pancreatectomy for pancreatic tail cancer: A multicenter cohort study. Eur J Surg Oncol Lee JS, Cassese G, Yoon YS, Han HS, Lee B, Park Y, Jang JY, Kwon W, Lim CS. PMID: 41539036 [PubMed - as supplied by publisher]
	Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. JCO Precis Oncol Gamboa AC, Lewis KA, Prakash LR, Li Z, Qiao W, Zhao D, Hurd MW, Yousef M, Ikoma N, Kim MP, Lee JE, Maxwell JE, Tzeng CD, Katz MHG, Snyder RA. PMID: 41538760 [PubMed - indexed for MEDLINE]
	Contemporary Multidisciplinary Treatment of Borderline-Resectable and Locally Advanced Pancreatic Adenocarcinoma. Am Soc Clin Oncol Educ Book Joung RH, Snyder RA. PMID: 41538745 [PubMed - indexed for MEDLINE]
	A commentary on "Multimodal radiopathomics approach for predictions of prognosis and immunotherapy response in patients with gastric cancer: a multicohort retrospective study". Int J Surg Mohetaer A, Adili D. PMID: 41537318 [PubMed - as supplied by publisher]
	The expression of genes KRAS, DPM1, ACRV1, and MBD3L2 in the saliva as potential tumor markers in the detection of pancreatic cancer. Pol Przegl Chir Ciosek J, Dranka-Bojarowska D, Lewi, Lampe P. PMID: 41537300 [PubMed - indexed for MEDLINE]
	The Predictive Performance of Tumor Morphological Features on MRI Combined With Serum CA19-9 for the Efficacy of TACE Treatment in Patients With Primary Liver Cancer. Ann Ital Chir Shen M, Zhang W, Shen H, Wang B. PMID: 41537205 [PubMed - indexed for MEDLINE]
	Change in Liver Function after Selective Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: JIVROSG-2001 PRESIDENT-ALBI - A Secondary Analysis of a Multicenter Randomized Controlled Trial. Liver Cancer Kodama Y, Ikeda M, Arai Y, Inaba Y, Tanaka T, Arai Y, Sugawara S, Yamazaki H, Aramaki T, Anai H, Morita S, Fujinaga Y, Seki H, Sato M, Kamimura K, Ito J, Tsurusaki M, Nakazawa T, Tokue H, Abo D, Kato K, Hayashi N, Sato O, Sone M. PMID: 41536555 [PubMed - as supplied by publisher]
	Prognosis of liver transplantation and hepatectomy in patients with hepatocellular carcinoma meeting the Milan criteria: A systematic review and meta-analysis. Oncol Lett Wang J, Pan Z, Wang Y, Ye Y, Li W. PMID: 41536546 [PubMed]
	Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemcitabine and NAB-paclitaxel therapy in advanced pancreatic cancer. BMC Cancer Easty D, McDermott R, Murphy AG, Grogan L, Morris PG, Breathnach OS, Egan K, Toomey S, Horgan A, Power D, Osman N, Parker I, Donachie V, Shevlin A, Barrett A, Nolan M, Marron J, Farr CJ, Hennessy BT. PMID: 41535788 [PubMed - as supplied by publisher]
	Associations between changes in MASLD status and cancer development in young adults: A nationwide cohort study. Eur J Cancer Chung GE, Yu SJ, Park J, Kim YJ, Yoon JH, Han K, Cho EJ. PMID: 41534486 [PubMed - as supplied by publisher]
	Cannabis Use Disorder and Risk of Pancreatic Cancer in Patients with Chronic Pancreatitis: a Multicenter Retrospective Cohort Study. J Gastrointest Cancer Maan MHA, Maan S, Ahmad MM, Goyal RM, Khan S, Waleed M, Qureshi I, Hajifathalian K, Al-Khazraji A. PMID: 41533288 [PubMed - indexed for MEDLINE]
	From bench to bedside: pancreatic juice as a platform for biomarker discovery in pancreatic disease. Korean J Intern Med Siddappa PK, Kong N, Lee A, Jiang Y, Park WG. PMID: 41531214 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 58795

Page 1 de 2940



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité